Skip to main content

Table 5 The 5-year follow-up parameters for skin and lung involvement were indicated for HSCT and control groups A and B. The body mass index (BMI) was the lowest in the HSCT group and remained stable over the following 5 years

From: Autologous hematopoietic stem cell transplantation improves long-term survival—data from a national registry

Follow-up

Year 0

Year 1

Year 3

Year 5

all dc-SSc controls A (n=1513)

    

mRSS  (mean ± SD)

15.6 ± 9.9

12.8 ± 8.8

12.1 ± 8.5

12.4 ± 9.0

N valid; p-value*

1242; reference

594; <0.001

361; <0.001

299; 0.191

DLCO SB (%) (mean ± SD)

63.2 ± 21.9

63.0 ± 21.8

61.2 ± 20.0

60.7 ± 20.3

N valid; p-value*

872; reference

455; 0.015

256; <0.001

216; <0.001

BMI (kg/m2) (mean ± SD)

24.3 ± 4.6

24.5 ± 4.8

24.2 ± 4.6

24.3 ± 4.8

N valid; p-value*

758; reference

402; 0.577

311; 0.971

285; 0.417

male Scl70+ dc-SSc controls B (n=240)

    

mRSS  (mean ± SD)

17.2 ± 9.7

14.2 ± 12.0

15.9 ± 9.0

15.5 ± 9.0

N valid; p-value*

218; reference

93; 0.050

45; 0.581

40; 0.957

DLCO SB (%) (mean ± SD)

59.1 ± 21.3

58.3 ± 23.7

56.7 ± 22.6

58.2 ± 25.3

N valid; p-value*

163; reference

78; 0.135

29; 0.192

35; 0.032

BMI (kg/m2) (mean ± SD)

25.0 ± 4.5

24.8 ± 4.1

25.0 ± 3.5

25.0 ± 4.1

N valid; p-value*

142; reference

68; 0.373

41; 0.948

38; 0.258

HSCT SSc (n=79)

    

mRSS (mean ± SD)

17.6 ± 11.5

12.1 ± 8.6

13.6 ± 8.7

11.0 ± 8.5

N valid; p-value*

72; reference

57; <0.001

34; 0.006

33; 0.001

DLCO SB (%) (mean ± SD); p

54.6 ± 17.8

61.2 ± 21.0

55.6 ± 15.6

60.0 ± 18.5

N valid; p-value*

55; reference

47; 0.222

24; 0.980

20; 0.964

BMI (kg/m2) (mean ± SD); p

22.9 ± 4.1

23.0 ± 4.6

22.6 ± 3.9

22.8 ± 3.6

N valid; p-value*

56; reference

47; 0.844

33; 0.727

32; 0.175